Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholinergic antagonists and REM sleep generation.

J Velazquez-Moctezuma1, M Shalauta, J C Gillin

  • 1Department of Psychiatry, San Diego VA Medical Center (V-116A), La Jolla, CA.

Brain Research
|March 8, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep.

Brain, behavior, and immunity·2017
Same author

Chronic sleep restriction disrupts interendothelial junctions in the hippocampus and increases blood-brain barrier permeability.

Journal of microscopy·2017
Same author

Blood-Brain Barrier Disruption Induced by Chronic Sleep Loss: Low-Grade Inflammation May Be the Link.

Journal of immunology research·2016
Same author

Effect of low-frequency repetitive transcranial magnetic stimulation on sleep pattern and quality of life in patients with focal epilepsy.

Sleep medicine·2016
Same author

Functional brain imaging, sleep, and sleep deprivation: contributions to the "overarousal" hypothesis of depression.

Acta neuropsychiatrica·2016
Same author

Polysomnographic features in infants with early diagnosis of congenital hypothyroidism.

Brain & development·2009
Same journal

IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma.

Brain research·2026
Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026
Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026
Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026
Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026
Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026
See all related articles

Cholinergic stimulation of REM sleep in cats is mediated by a non-M1 muscarinic receptor. This study investigated M1 and M2 muscarinic receptors in the brainstem, identifying a specific receptor subtype involved in REM sleep.

Area of Science:

  • Neuroscience
  • Sleep Research
  • Pharmacology

Background:

  • Cholinergic pathways in the brainstem are crucial for regulating sleep-wake states.
  • Muscarinic receptors, specifically M1 and M2 subtypes, are implicated in mediating cholinergic effects on sleep.
  • Previous observations suggested a role for these receptors in the induction of Rapid Eye Movement (REM) sleep.

Purpose of the Study:

  • To further investigate the specific roles of M1 and M2 muscarinic receptors in the cholinergic induction of REM sleep.
  • To determine the receptor subtype responsible for REM sleep generation in the medial pontine reticular formation (mPRF).

Main Methods:

  • Chronic implantation of sleep recording electrodes in cats.
  • Microinjections into the medial pontine reticular formation (mPRF) with Ringer's solution or muscarinic antagonists.

Related Experiment Videos

  • Administration of a specific M2 muscarinic agonist, cis-methyl-dioxolane (cisdioxo), following antagonist or Ringer's solution.
  • Assessment of REM sleep percentage changes in response to pharmacological manipulations.

    • Main Results:

    • Microinjection of cisdioxo significantly increased REM sleep percentage.
    • Atropine, a mixed muscarinic antagonist, blocked the cisdioxo-induced REM sleep increase.
    • Pirenzepine, a selective M1 antagonist, did not block the REM sleep increase.
    • Gallamine, a putative M2 antagonist, showed a tendency to inhibit the REM sleep increase.

    Conclusions:

    • The cholinergic stimulation that induces REM sleep in the mPRF is mediated by a non-M1 muscarinic receptor subtype.
    • These findings support the hypothesis that a specific, non-M1 muscarinic receptor is involved in REM sleep generation.
    • The results contribute to understanding the neurochemical mechanisms underlying REM sleep regulation.